carruthers.net

REFERRED PUBLICATIONS

PAGE [3]

Carruthers JDA. Commentary on Pyridostigmine for Botulinum toxin induced Ptosis.Dermatol. Surg.33:11:November 2007: 3-4.
Carruthers JDA, Carruthers JA. The Evolution of the Cosmetic Use of the Botulinum Neurotoxins. Journal of Cosmetic and Laser Therapy. 2007;000-1-7.
Hirsch R, , Carruthers J , Brody H : Hyaluronidase in the office: A necessity for every dermasurgeon that injects hyaluronic acid . Journal of Cosmetic and Laser Therapy Manuscript ID: 229071, Journal of Cosmetic and Laser Therapy, Volume 9, Issue 3 2007 , pages 182 - 185
Online version:
http://www.informaworld.com/smpp/content~content=a777402572~db
=all~order=pubdate
21) Alastair Carruthers, MD1, Marc Liebeskind, MD, JD2, Jean Carruthers3, MD, Bruce B. Forster, MD4Radiographic and Computed Tomographic Studies of Calcium Hydroxylapatite for Treatment of HIV-associated Facial Lipoatrophy and Correction of Nasolabial Folds
Accepted by Dermatologic Surgery August 13, 2007.
Alastair Carruthers. Jean Carruthers. Patient Reported Outcomes with Botulinum neurotoxin type A.Journal of Cosmetic and Laser Therapy. 2007;9(suppl 1):32-27. 4

ion3